A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma
Clinical trial NCT06413498 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06413498
- Sponsor
- Kite, A Gilead Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-23
- Primary completion
- 2028-07-01
- Enrollment
- 452
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.